EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Fragmented Thresholds, Unified Vision: Advancing Salivary Diagnostics for OSCC and OPMD

Hichem Moulahoum iD, Faezeh Ghorbanizamani iD

Journal of Oral Pathology & Medicine · 2026-08 · 55 (7) · 729-731

DOI: 10.1111/jop.70141 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Oral Pathology & Medicine, online erschienen am 15.04.2026. Verfasst von Hichem Moulahoum und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Science, Ege University, Izmir, Türkiye. Hauptthemen laut MEDLINE: Saliva, Mouth Neoplasms, Carcinoma, Squamous Cell, Precancerous Conditions. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Türkiye Sağlık Enstitüleri Başkanlığı, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salivary diagnostics for oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD) have advanced significantly, yet clinical translation remains limited. A key barrier is the lack of harmonized thresholds for candidate biomarkers, ranging from cytokines to genetic and epigenetic markers, across studies. This variability undermines biosensor calibration, impedes algorithmic integration, and restricts the scalability of AI and eHealth tools. Paradoxically, saliva is well‐established in systemic disease diagnostics but remains undervalued in oral oncology. Recent initiatives, such as COST Action CA21140—INTERCEPTOR, are working to intercept oral carcinogenesis through collaborative innovation in molecular diagnostics and surveillance technologies. This letter calls for standardized protocols, multicenter validation, and digital integration to unlock saliva's full potential as a frontline diagnostic fluid. By addressing biomarker variability and embracing cross‐sector collaboration, the field can move toward clinically actionable, digitally enabled solutions for early detection and monitoring of OSCC and OPMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SalivaMouth NeoplasmsCarcinoma, Squamous CellPrecancerous ConditionsHumansBiomarkers, Tumor

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Biochemistry Department, Faculty of Science, Ege University, Izmir, Türkiye.

ORCID-Profile: Hichem Moulahoum, Faezeh Ghorbanizamani

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
  • Türkiye Sağlık Enstitüleri Başkanlığı
  • European Cooperation in Science and Technology

Zitieren

APA

Moulahoum, H., & Ghorbanizamani, F. (2026). Fragmented Thresholds, Unified Vision: Advancing Salivary Diagnostics for OSCC and OPMD. Journal of Oral Pathology & Medicine, 55(7), 729-731. https://doi.org/10.1111/jop.70141

Vancouver

Moulahoum H, Ghorbanizamani F. Fragmented Thresholds, Unified Vision: Advancing Salivary Diagnostics for OSCC and OPMD. Journal of Oral Pathology & Medicine. 2026;55(7):729-731. doi:10.1111/jop.70141

BibTeX
@article{Moulahoum2026,
  author = {Moulahoum, Hichem and Ghorbanizamani, Faezeh},
  title = {Fragmented Thresholds, Unified Vision: Advancing Salivary Diagnostics for OSCC and OPMD},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2026},
  volume = {55},
  number = {7},
  pages = {729--731},
  doi = {10.1111/jop.70141}
}
Kostenlos starten →